double-skinned crabsVietnamese crab exporter
Advertisement
HKEX
Business

HKEX to roll out new weekly options, biotech futures amid trading boom

Exchange expands derivatives lineup to meet investor hedging demand after record turnover this year

2-MIN READ2-MIN
Listen
Hong Kong has risen to become the world’s second-largest IPO venue for biotech companies after New York. Photo: Xinhua
Enoch Yiu

Hong Kong Exchanges and Clearing (HKEX) will launch five new weekly stock options and a Hang Seng Biotech Index Futures contract this month, expanding hedging tools for investors as derivatives trading on the bourse hits record levels, a senior executive said.

The new weekly stock options – tracking CNOOC, China Mobile, AIA Group, Xiaomi and Semiconductor Manufacturing International Corporation (SMIC) – will begin trading on November 10, while the biotech futures contract will debut on November 28.

HKEX’s average daily turnover of equity-derivative contracts rose 7 per cent year on year to 1.54 million in the first nine months of 2025, putting the exchange on track for a third straight record year, according to exchange data.

Select Voice
Select Speed
1x
AI-generated voice